A cluster of acute thebaine poisonings from non-food grade poppy seeds in the Australian food supply.


Journal

Clinical toxicology (Philadelphia, Pa.)
ISSN: 1556-9519
Titre abrégé: Clin Toxicol (Phila)
Pays: England
ID NLM: 101241654

Informations de publication

Date de publication:
09 2023
Historique:
medline: 22 11 2023
pubmed: 19 10 2023
entrez: 19 10 2023
Statut: ppublish

Résumé

Poppy seed tea is used for its opioid effects and contains multiple opium alkaloids, including morphine, codeine, papaverine, and thebaine. Animal studies indicate thebaine has strychnine-like properties, but there is limited literature describing human thebaine poisoning. We describe a cluster of acute thebaine poisoning in people ingesting tea made using poppy seeds with high thebaine content that entered the Australian food supply chain. This is an observational study of patients poisoned after drinking poppy seed tea. Cases were identified by three prospective toxicovigilance systems: the Emerging Drug Network of Australia collaboration, the New South Wales Prescription, Recreational and Illicit Substance Evaluation program, and the Emerging Drugs Network of Australia Victoria study. We report characteristics of clinical toxicity in cases with reported ingestion of poppy seed tea and analytical confirmation of thebaine exposure. Forty cases presenting with multi-system toxicity following poppy seed tea ingestion were identified across seven Australian states/territories from November 2022 to January 2023. Blood testing in 23 cases confirmed high thebaine concentrations. All 23 were male (median age 35, range 16-71 years). All patients experienced muscle spasms. Rigidity was described in nine, convulsions in six, while rhabdomyolysis, acute kidney injury, and metabolic acidosis occurred in five patients. There were two cardiac arrests. The thebaine median admission blood concentration was 1.6 mg/L, with a range of 0.1-5.6 mg/L, and was the dominant opium alkaloid in all samples. Convulsions, acute kidney injury, metabolic acidosis, and cardiac arrest were associated with increasing median thebaine concentrations. Four patients were managed in the Intensive Care Unit, with two receiving continuous kidney replacement therapy (one also received intermittent haemodialysis) for kidney injury. There was one death. Thebaine toxicity, like strychnine poisoning, resulted in neuromuscular excitation characterized by muscle spasm, rigidity, and convulsions. Severe toxicity, including acute kidney injury, metabolic acidosis, and cardiac arrest, appears dose-dependent.

Identifiants

pubmed: 37855308
doi: 10.1080/15563650.2023.2265053
doi:

Substances chimiques

Thebaine 2P9MKG8GX7
Opium 8008-60-4
Strychnine H9Y79VD43J
Morphine 76I7G6D29C
Codeine UX6OWY2V7J
Tea 0

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

639-643

Auteurs

Katherine Z Isoardi (KZ)

Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, Australia.
Queensland Poisons Information Centre, Queensland Children's Hospital, Brisbane, Australia.
Faculty of Medicine, University of Queensland, Brisbane, Australia.

Darren M Roberts (DM)

NSW Poisons Information Centre, Sydney Children's Hospitals Network, Sydney, Australia.
Edith Collins Centre, Drug Health Services, Royal Prince Alfred Hospital, Sydney, Australia.

Amanda G Holford (AG)

Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, Australia.
Queensland Poisons Information Centre, Queensland Children's Hospital, Brisbane, Australia.
Faculty of Medicine, University of Queensland, Brisbane, Australia.

Jared A Brown (JA)

NSW Poisons Information Centre, Sydney Children's Hospitals Network, Sydney, Australia.
Centre for Alcohol and Other Drugs, NSW Ministry of Health, Sydney, Australia.

Andrew Griffiths (A)

Forensic Toxicology, Forensic and Scientific Services, Brisbane, Australia.

Jessamine Soderstrom (J)

Centre of Clinical Research in Emergency Medicine, Emergency Department, Royal Perth Hospital, Perth, Australia.

Catherine McDonald (C)

Forensic Toxicology, Forensic & Analytical Science Service, NSW Health Pathology, Sydney, Australia.

Dimitri Gerostamoulos (D)

Department of Forensic Medicine, Monash University, Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.

Paul Sakrajda (P)

Forensic Science Laboratory, ChemCentre, Perth, Australia.

Claire Turner (C)

NSW Poisons Information Centre, Sydney Children's Hospitals Network, Sydney, Australia.
Centre for Alcohol and Other Drugs, NSW Ministry of Health, Sydney, Australia.

Hans Yates (H)

Organic Chemistry, Forensic and Scientific Services, Brisbane, Australia.

Naren Gunja (N)

NSW Poisons Information Centre, Sydney Children's Hospitals Network, Sydney, Australia.
Dept of Clinical Pharmacology & Toxicology, Western Sydney Health, Sydney, Australia.

Shaun Greene (S)

Victorian Poisons Information Centre, Austin Hospital, Melbourne, Australia.
Department of Critical Care, University of Melbourne, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH